Target Name: RBM12
NCBI ID: G10137
Review Report on RBM12 Target / Biomarker Content of Review Report on RBM12 Target / Biomarker
RBM12
Other Name(s): RNA-binding protein 12 | SWAN | SH3/WW domain anchor protein in the nucleus | RBM12 variant 1 | RNA-binding motif protein 12 | RNA binding motif protein 12, transcript variant 1 | HRIHFB2091 | RNA binding motif protein 12 | KIAA0765 | RBM12_HUMAN | OTTHUMP00000062718 | SCZD19

RBM12: A Drug Target / Disease Biomarker

RBM12 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the BMP-2 (basic Maintenance Plasma Membrane) family, which is a group of proteins that are involved in cell-cell signaling and tissue regeneration.

One of the functions of RBM12 is to regulate the formation of new blood vessels in the brain. This is important for the development and maintenance of new neural connections, which are critical for learning and memory. RBM12 has been shown to play a role in the formation of new blood vessels in the brain, and may be a potential drug target for the treatment of various neurological disorders.

In addition to its role in blood vessel formation, RBM12 is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the development and maintenance of various tissues in the body, including the brain, heart, and lungs.

RBM12 is also involved in the regulation of cellular signaling pathways that are important for both cell growth and differentiation. It has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway, which is involved in cell growth and differentiation, and the Wnt pathway, which is involved in the regulation of cell growth and differentiation.

In conclusion, RBM12 is a protein that is involved in a variety of physiological processes in the body. Its functions in cell-cell signaling, blood vessel formation, and tissue regeneration make it a potential drug target for the treatment of various neurological disorders. Further research is needed to fully understand the role of RBM12 in the development and maintenance of various tissues in the body, and to determine its potential as a drug target.

Protein Name: RNA Binding Motif Protein 12

The "RBM12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL | RBPJP2 | RBPMS | RBPMS-AS1 | RBPMS2 | RBSN | RBX1 | RC3H1 | RC3H2 | RCAN1 | RCAN2 | RCAN3 | RCAN3AS | RCBTB1 | RCBTB2 | RCC1 | RCC1L | RCC2 | RCCD1 | RCE1 | RCHY1 | RCL1 | RCN1 | RCN1P2 | RCN2 | RCN3 | RCOR1 | RCOR2 | RCOR3 | RCSD1 | RCVRN | RD3